Literature DB >> 25637466

Establishment of intervertebral disc degeneration model induced by ischemic sub-endplate in rat tail.

Wei Yuan1, Wu Che2, Yun-Qi Jiang2, Feng-Lai Yuan2, Hui-Ren Wang2, Guo-Li Zheng2, Xi-Lei Li3, Jian Dong4.   

Abstract

BACKGROUND CONTEXT: Microcirculatory dysfunction of the sub-endplate is considered to reduce nutrient supply to the intervertebral disc (IVD); however, direct interruption or destruction of blood vessels in the bone marrow of the vertebrae body adjacent to the endplate has not yet been described, especially with regard to the calcification and ossification of the cartilaginous endplate occurring during IVD degeneration.
PURPOSE: The purpose of the study was to evaluate the causal relationship between IVD degeneration and blocking of the main blood supply gateway through the endplate. STUDY DESIGN/
SETTING: The study describes a new IVD degeneration model induced by ischemic sub-endplate. PATIENT SAMPLE: A total of 40 Sprague-Dawley rats were included in the study group. OUTCOME MEASURES: To assess disc height, a radiograph was taken each month for 4 months. Changes in endplate, nucleus pulposus (NP), and annulus fibrosus (AF) were evaluated by histochemical and immunohistochemical staining to detect IVD degeneration.
METHODS: Injection of 30 μL absolute ethanol into the IVD of rat tail at Co7/Co8 was used to induce injury. Controls were injected with 30 μL of phosphate-buffered saline into the IVD at Co8/Co9.
RESULTS: In the ethanol-injected group, disc height gradually decreased and bone sclerosis developed in the endplate. In the NP, cell transformation occurred, changing from predominantly vacuolar cells to chondrogenic cells and eventually fibrocartilaginous cells, along with fibrosis of the NP. As degeneration progressed, the AF developed disordered morphology and rough lamellae, and eventually ruptures and fibrosis. The extent of degeneration increased gradually over time, while the wavy tidemark of the growth plate regressed, and eventually disappeared. Initially positive collagen type II staining gradually decreased on the ischemic side of the sub-endplate. Except at the 3-month time point, expression of collagen type II, aggrecan, and Sox-9 in NP decreased gradually as degeneration progressed, compared with the control group.
CONCLUSIONS: This model successfully reproduced IVD degeneration, which could be used for etiological studies on IVD degeneration and investigation of nutrient supply disturbance, and may provide a theoretical foundation for clinical intervention and therapy for IVD degeneration in the future.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Absolute ethanol; Animal model; Endplate; Intervertebral disc degeneration; Rat tail

Mesh:

Year:  2015        PMID: 25637466     DOI: 10.1016/j.spinee.2015.01.026

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  15 in total

1.  Quantitative MRI correlates with histological grade in a percutaneous needle injury mouse model of disc degeneration.

Authors:  Matthew Piazza; Sun H Peck; Sarah E Gullbrand; Justin R Bendigo; Toren Arginteanu; Yejia Zhang; Harvey E Smith; Neil R Malhotra; Lachlan J Smith
Journal:  J Orthop Res       Date:  2018-05-24       Impact factor: 3.494

Review 2.  Animal models for disc degeneration-an update.

Authors:  Li Jin; Gary Balian; Xudong Joshua Li
Journal:  Histol Histopathol       Date:  2017-06-05       Impact factor: 2.303

Review 3.  Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration.

Authors:  Yizhong Peng; Xiangcheng Qing; Hongyang Shu; Shuo Tian; Wenbo Yang; Songfeng Chen; Hui Lin; Xiao Lv; Lei Zhao; Xi Chen; Feifei Pu; Donghua Huang; Xu Cao; Zengwu Shao
Journal:  Biomater Transl       Date:  2021-06-28

4.  Cyclooxygenase-2 deficiency causes delayed ossification of lumbar vertebral endplates.

Authors:  Qingfeng Ding; Yongxin Ren; Hui Che; Cheng Ma; Huiwu Li; Suojing Yu; Yejia Zhang; Howard An; Regis J O'Keefe; Di Chen; Joel A Block; Guoyong Yin; Tianfang Li
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

5.  Bone mesenchymal stem cell-derived extracellular vesicles promote the repair of intervertebral disc degeneration by transferring microRNA-199a.

Authors:  Tao Wen; Hongshen Wang; Yongjin Li; Yongpeng Lin; Shuai Zhao; Jinggong Liu; Bolai Chen
Journal:  Cell Cycle       Date:  2021-01-26       Impact factor: 4.534

6.  Autophagy Is a Protective Response to the Oxidative Damage to Endplate Chondrocytes in Intervertebral Disc: Implications for the Treatment of Degenerative Lumbar Disc.

Authors:  Ke Chen; Xiaohua Lv; Wei Li; Fei Yu; Jianjing Lin; Junxuan Ma; Deming Xiao
Journal:  Oxid Med Cell Longev       Date:  2017-02-22       Impact factor: 6.543

7.  MicroRNA-143-5p targeting eEF2 gene mediates intervertebral disc degeneration through the AMPK signaling pathway.

Authors:  Qi Yang; Xiao-Peng Guo; Yan-Li Cheng; Yang Wang
Journal:  Arthritis Res Ther       Date:  2019-04-15       Impact factor: 5.156

8.  Inhibition of EZH2 ameliorates cartilage endplate degeneration and attenuates the progression of intervertebral disc degeneration via demethylation of Sox-9.

Authors:  Chao Jiang; Qiang Guo; Yu Jin; Jia-Jing Xu; Ze-Ming Sun; Ding-Chao Zhu; Jia-Hao Lin; Nai-Feng Tian; Liao-Jun Sun; Xiao-Lei Zhang; Yao-Sen Wu
Journal:  EBioMedicine       Date:  2019-10-17       Impact factor: 8.143

9.  Osteoporosis of the vertebra and osteochondral remodeling of the endplate causes intervertebral disc degeneration in ovariectomized mice.

Authors:  Zhi-Feng Xiao; Jian-Bo He; Guo-Yi Su; Mei-Hui Chen; Yu Hou; Shu-Dong Chen; Ding-Kun Lin
Journal:  Arthritis Res Ther       Date:  2018-09-10       Impact factor: 5.156

10.  Puerarin Relieved Compression-Induced Apoptosis and Mitochondrial Dysfunction in Human Nucleus Pulposus Mesenchymal Stem Cells via the PI3K/Akt Pathway.

Authors:  Donghua Huang; Yizhong Peng; Kaige Ma; Xiangcheng Qing; Xiangyu Deng; Zhiliang Li; Zengwu Shao
Journal:  Stem Cells Int       Date:  2020-01-11       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.